Pharmaceutical

STAT+: Pharmalittle: FDA slams company recalling eye dr...

Good morning, everyone, and welcome to another working week. We hope the weekend...

STAT+: Vertex, CRISPR Therapeutics inch ahead of rival ...

Vertex Pharmaceuticals and its partner CRISPR Therapeutics said they had met the...

Why the early tests of ChatGPT in medicine miss the mark

Stanford researchers asked GPT-4 questions about real-life medical situations. T...

STAT+: A devastating skin condition could soon get its ...

B-VEC — which is dripped onto wounds from a syringe — would be the first topical...

STAT+: The biotech scorecard for the second quarter: 24...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech eve...

Opinion: Emergency rooms need clear guidelines about ho...

Emergency medicine workers need guidance on what to do when a police officer ref...

‘If we don’t, others will’: White House Covid adviser c...

Ashish Jha called on doctors to battle medical misinformation and disinformation...

STAT+: Biden administration goes easy on Medicare Advan...

The Biden administration is going easy on Medicare Advantage insurers, after an ...

STAT+: European Union drug pricing proposal for the pan...

"The European Commission has always been fond of tiered pricing, despite the gro...

STAT+: Inflation caused a sizable drop in net drug pric...

A new analysis finds that after accounting for inflation, wholesale prices of br...

STAT+: FDA report details problems at Global Pharma pla...

The FDA inspection occurred shortly after Global Pharma Healthcare recalled two ...

STAT+: Pharmalittle: Judge blocks required ACA coverage...

A federal judge reversed a major Obamacare provision requiring plans to cover pr...

Opinion: STAT+: 3 keys to successful biopharma-academia...

Improving the efficiency of research partnerships is important to accelerate the...

Genetic differences in breast tumors may contribute to ...

"It tells you that when two groups of people with different ancestry get the sam...

Trans health care, already under attack, faces new obst...

A looming change to U.S. telehealth rules could curtail trans people's access to...

Small and medium biotechs jump on obesity train

Small and medium biotechs join the hunt for new obesity therapies amidst a backd...